pubmed-article:17719768 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:17719768 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
pubmed-article:17719768 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
pubmed-article:17719768 | lifeskim:mentions | umls-concept:C0018801 | lld:lifeskim |
pubmed-article:17719768 | lifeskim:mentions | umls-concept:C0034802 | lld:lifeskim |
pubmed-article:17719768 | lifeskim:mentions | umls-concept:C1522564 | lld:lifeskim |
pubmed-article:17719768 | lifeskim:mentions | umls-concept:C0876994 | lld:lifeskim |
pubmed-article:17719768 | lifeskim:mentions | umls-concept:C0017262 | lld:lifeskim |
pubmed-article:17719768 | lifeskim:mentions | umls-concept:C0003234 | lld:lifeskim |
pubmed-article:17719768 | lifeskim:mentions | umls-concept:C0441712 | lld:lifeskim |
pubmed-article:17719768 | lifeskim:mentions | umls-concept:C2911684 | lld:lifeskim |
pubmed-article:17719768 | lifeskim:mentions | umls-concept:C0185117 | lld:lifeskim |
pubmed-article:17719768 | pubmed:issue | 14 | lld:pubmed |
pubmed-article:17719768 | pubmed:dateCreated | 2007-9-17 | lld:pubmed |
pubmed-article:17719768 | pubmed:abstractText | Trastuzumab can induce cardiotoxicity, particularly when combined with anthracyclines. Myocardial human epidermal growth factor receptor 2 (HER2) expression may be transiently upregulated by a compensatory mechanism following cardiac stress. 111In-DTPA-trastuzumab, scintigraphy can detect HER2 positive tumour lesions, however previously, we found myocardial uptake in only 1 of the 15 anthracycline-pre-treated patients with a median of 11 months after the last anthracycline administration. To evaluate whether myocardial HER2 expression is upregulated by anthracycline-induced cardiac stress or in case of heart failure by chronic pressure or volume overload, we performed 111In-DTPA-trastuzumab scans in patients shortly after anthracyclines and with non-anthracycline-related heart failure. | lld:pubmed |
pubmed-article:17719768 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17719768 | pubmed:language | eng | lld:pubmed |
pubmed-article:17719768 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17719768 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:17719768 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17719768 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17719768 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17719768 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17719768 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17719768 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17719768 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17719768 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:17719768 | pubmed:month | Sep | lld:pubmed |
pubmed-article:17719768 | pubmed:issn | 0959-8049 | lld:pubmed |
pubmed-article:17719768 | pubmed:author | pubmed-author:SluiterW JWJ | lld:pubmed |
pubmed-article:17719768 | pubmed:author | pubmed-author:SleijferD TDT | lld:pubmed |
pubmed-article:17719768 | pubmed:author | pubmed-author:GietemaJ AJA | lld:pubmed |
pubmed-article:17719768 | pubmed:author | pubmed-author:van... | lld:pubmed |
pubmed-article:17719768 | pubmed:author | pubmed-author:SuterT MTM | lld:pubmed |
pubmed-article:17719768 | pubmed:author | pubmed-author:JagerP LPL | lld:pubmed |
pubmed-article:17719768 | pubmed:author | pubmed-author:de VriesE G... | lld:pubmed |
pubmed-article:17719768 | pubmed:author | pubmed-author:van der... | lld:pubmed |
pubmed-article:17719768 | pubmed:author | pubmed-author:Lub-de... | lld:pubmed |
pubmed-article:17719768 | pubmed:author | pubmed-author:PerikP JPJ | lld:pubmed |
pubmed-article:17719768 | pubmed:author | pubmed-author:de KorteM AMA | lld:pubmed |
pubmed-article:17719768 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:17719768 | pubmed:volume | 43 | lld:pubmed |
pubmed-article:17719768 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:17719768 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:17719768 | pubmed:pagination | 2046-51 | lld:pubmed |
pubmed-article:17719768 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
pubmed-article:17719768 | pubmed:meshHeading | pubmed-meshheading:17719768... | lld:pubmed |
pubmed-article:17719768 | pubmed:meshHeading | pubmed-meshheading:17719768... | lld:pubmed |
pubmed-article:17719768 | pubmed:meshHeading | pubmed-meshheading:17719768... | lld:pubmed |
pubmed-article:17719768 | pubmed:meshHeading | pubmed-meshheading:17719768... | lld:pubmed |
pubmed-article:17719768 | pubmed:meshHeading | pubmed-meshheading:17719768... | lld:pubmed |
pubmed-article:17719768 | pubmed:meshHeading | pubmed-meshheading:17719768... | lld:pubmed |
pubmed-article:17719768 | pubmed:meshHeading | pubmed-meshheading:17719768... | lld:pubmed |
pubmed-article:17719768 | pubmed:meshHeading | pubmed-meshheading:17719768... | lld:pubmed |
pubmed-article:17719768 | pubmed:meshHeading | pubmed-meshheading:17719768... | lld:pubmed |
pubmed-article:17719768 | pubmed:meshHeading | pubmed-meshheading:17719768... | lld:pubmed |
pubmed-article:17719768 | pubmed:meshHeading | pubmed-meshheading:17719768... | lld:pubmed |
pubmed-article:17719768 | pubmed:meshHeading | pubmed-meshheading:17719768... | lld:pubmed |
pubmed-article:17719768 | pubmed:meshHeading | pubmed-meshheading:17719768... | lld:pubmed |
pubmed-article:17719768 | pubmed:meshHeading | pubmed-meshheading:17719768... | lld:pubmed |
pubmed-article:17719768 | pubmed:meshHeading | pubmed-meshheading:17719768... | lld:pubmed |
pubmed-article:17719768 | pubmed:meshHeading | pubmed-meshheading:17719768... | lld:pubmed |
pubmed-article:17719768 | pubmed:meshHeading | pubmed-meshheading:17719768... | lld:pubmed |
pubmed-article:17719768 | pubmed:meshHeading | pubmed-meshheading:17719768... | lld:pubmed |
pubmed-article:17719768 | pubmed:meshHeading | pubmed-meshheading:17719768... | lld:pubmed |
pubmed-article:17719768 | pubmed:meshHeading | pubmed-meshheading:17719768... | lld:pubmed |
pubmed-article:17719768 | pubmed:year | 2007 | lld:pubmed |
pubmed-article:17719768 | pubmed:articleTitle | 111Indium-trastuzumab visualises myocardial human epidermal growth factor receptor 2 expression shortly after anthracycline treatment but not during heart failure: a clue to uncover the mechanisms of trastuzumab-related cardiotoxicity. | lld:pubmed |
pubmed-article:17719768 | pubmed:affiliation | Department of Medical Oncology, University of Groningen and University Medical Centre Groningen, PO Box 30.001, 9700 RB Groningen, The Netherlands. | lld:pubmed |
pubmed-article:17719768 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:17719768 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17719768 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17719768 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17719768 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17719768 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17719768 | lld:pubmed |